Fertility Clock Headlines, Fertility Headlines

Female Reproductive Tract Not a Sterile Environment, Study Finds

Researchers have found bacteria in women’s ovaries and fallopian tubes — locations previously believed to be sterile. The investigators also discovered that women with ovarian cancer have a different bacterial population in these locations than women without the cancer. This finding raises the question of whether bacteria in the upper reproductive tract might play a role in the development or progression of ovarian cancer.

Fertility Clock Headlines, Fertility Headlines

Level of Hormone Can Predict Bone Loss in Menopause, Study Says

Lower levels of a hormone produced by the ovaries is associated with a woman’s risk for bone loss during menopause, according to a recent study. Researchers at the University of California Los Angeles found testing levels of anti-mullerian hormone in women who are pre- or early-menopausal shows their likely rate for bone loss, suggesting early intervention may be possible to slow or prevent the condition.

Fertility Clock Headlines, Fertility Headlines

Healthy Living: Male Infertility: The Other Half of the Equation

When you think about the subject of infertility, it is customary to focus on the challenges faced by women who may have to suffer though an expensive and physically demanding process known as In-Vitro Fertilization. This long road entails procedures to harvest the eggs from the ovaries, implant the embryos in the uterus and then carry a stressful pregnancy, frequently complicated by multiple gestations and the risk of miscarriage to term. However, as we all know, it ‘takes two to tango’ and often there is less discussion and awareness of the male side of the equation. Indeed, it is estimated that 40-50% of human infertility can be explained by ‘male factors’, and science is increasingly gaining insight into the requirements necessary for healthy male fertility.

Fertility Clock Headlines, Fertility Headlines

SOFT Yields Hard Data on Hormone Therapy

For decades, we have been wondering whether suppression of the ovaries in addition to tamoxifen would improve the outcomes of women with hormone-receptor–positive premenopausal breast cancer. The SOFT trial was designed to address that question on the basis of a lot of data that suggested that it might help, especially in very young women.